公开(公告)号：US07259163B2

公开(公告)日：2007-08-21

申请号：US10494127

申请日：2002-10-30

申请人： Gianpaolo Bravi ,  Rossella Guidetti ,  David Haigh ,  Charles David Hartley ,  Peter David Howes ,  Deborah Lynette Jackson ,  Victoria Lucy Helen Lovegrove ,  Pritom Shah ,  Martin John Slater ,  Katrina Jane Wareing

发明人： Gianpaolo Bravi ,  Rossella Guidetti ,  David Haigh ,  Charles David Hartley ,  Peter David Howes ,  Deborah Lynette Jackson ,  Victoria Lucy Helen Lovegrove ,  Pritom Shah ,  Martin John Slater ,  Katrina Jane Wareing

IPC分类号： A61K31/4965 ,  A01N43/54 ,  C07D239/42 ,  C07D241/00 ,  C07D241/02

CPC分类号： C07D401/14 ,  C07D403/04 ,  C07D409/14 ,  C07D417/14

摘要： Novel anti-viral agents of Formula wherein: A represents OR1, NR1R2, or R1 wherein R1 and R2 are hydrogen, C1-6alkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; or R1 and R2 together with the nitrogen atom to which they are attached form a 5 or 6 membered saturated cyclic group; B represents C(O)R3 wherein R3 is C1-6alkyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; C represents C1-6alkyl, aryl, heteroaryl or heterocyclyl; D represents a saturated or unsaturated optionally substituted 6-membered heterocyclic ring; E represents hydrogen or C1-6alkyl; F represents hydrogen, C1-6alkyl, aryl or heteroaryl; and G represents hydrogen, C1-6alkyl, heterocyclylalkyl, arylalkyl or heteroarylalkyl; and salts, solvates and esters thereof, processes for their preparation and methods of using them in HCV treatment are provided.

摘要翻译： 新型的下式的抗病毒剂，其中：A表示OR 1，NR 1，R 2，或R 1， 其中R 1和R 2是氢，C 1-6烷基，芳基，杂芳基，芳基烷基或杂芳基烷基; 或R 1和R 2与它们所连接的氮原子一起形成5或6元饱和环状基团; B表示C（O）R 3，其中R 3是C 1-6烷基，芳基，杂芳基，芳烷基或杂芳基烷基; C表示C 1-6烷基，芳基，杂芳基或杂环基; D表示饱和或不饱和的任选取代的6元杂环; E表示氢或C 1-6烷基; F表示氢，C 1-6烷基，芳基或杂芳基; 和G表示氢，C 1-6烷基，杂环基烷基，芳基烷基或杂芳基烷基; 提供其盐，溶剂合物和酯，其制备方法及其用于HCV治疗的方法。